We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products.
TAJ PHARMACEUTICALS LTD. (Pharmaceuticals Inc.) is a product-driven pharmaceutical company with diversified expertise. While TPL is relatively new to the US market, it is by no means a new player.
As a wholly owned subsidiary of TAJ PHARMACEUTICALS LTD.
Our product development and manufacturing capability, teamed with our ability to market products in many global markets, makes TPL an attractive business ally. A key part of our business strategy is to collaborate with partners with complementary skills - "A Win-Win" strategy that strengthens the position of our partners as well as TPL.
TPL has already experienced commercial success penetrating the US health care market, and looks forward to enhanced growth and future business opportunities through collaboration and strategic alliances.
The Beginnings with a basket including personal care, health care and other products, TAJ GROUP has set up Group Companies across the world that can manage its businesses more efficiently. Given the vast range of products, sourcing, production and marketing have been divested to leading group companies that conduct their operations independently.
Our company clear vision to bring Ayurveda to society in a contemporary form and to unravel the mystery behind the 5,000 year old system of medicine. This included referring to ancient ayurvedic texts, selecting indigenous herbs and subjecting the formulations to modern pharmacological, toxicological and safety tests to create new drugs and therapies. We export API, branded formulations and generic formulations to over 14 countries. Our inherent strength lies in identifying relevant API and formulations, and selling them at affordable prices across the world. All this has been possible because of our innovative and sustained marketing efforts. We are all set to spread our wings further and touch more lives across the globe.
As a responsible corporate citizen espoused to the cause of a better quality of life, Taj Pharmaceuticals accords high priority to Safety, Health and Environment. We are committed to protecting the environment we operate in, and ensuring the health and safety of our employees and stakeholders.
Our mission is to become the recognized leader in accelerating discovery and development of novel, small molecule drug therapies. The innovative application of our proprietary computational lead drug design technology provides the opportunity to substantially compress the time and cost of drug development and have a dramatic impact on important disease states.
Taj Pharmaceuticals products can broadly be categorized into four main ranges
The medicinal range broadly classified into four categories
Manufacturing and Facilities : The manufacturing facilities are based in Valsad (Gujarat) and Raigad (Raigarh, Maharashtra) and operated by Taj Pharmaceuticals Ltd and its subsidiaries.
In our quest to be the leading manufacturer in the pharmaceutical industry and a CRAMS player of global standing; we aspire to meet and excel the highest industry standards. To this end, on the manufacturing front, we have designed and engineered our production facilities to the most rigorous benchmarks.
We have a modern
facility for the production of sterile powder formulations, non-sterile oral formulations and active pharmaceutical ingredients.
Some other features of our facility:
- Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
- Fully automated with electronically controlled operating system as per Good Automated Manufacturing Practice guidelines (GMP).
- Sophisticated Effluent Treatment Plant (ETP) with a capacity of 100,000 liters per day.
- Conforms to international environmental, health & safety regulations
Our facility consistently meets and exceeds our own stringent quality assurance standards, administered by an Internal Quality Assurance team reporting directly to the Managing Director, as well as those imposed by regulatory bodies. IQ /OQ / PQ validations have been completed on all equipment to which these apply.
In addition, we are a registered drug manufacturing facility with an impressive inspection record. All our manufacturing sites are WHO-GMP approved.
Our expertise APIs (CTD & formulation dossiers) will help us further enhance our own product range as well as the size and diversity of our toll / contract manufacturing business segment.
Modern methods like aqueous coating, tablet packing in combi-packs etc., are implemented in the manufacturing process.
The Sarigam plant is the Only plant in the world producing all the effective ranges of Anti-tuberculosis formulations namely Ethambutol Hydrochloride (B.P.), Rifampicin (B.P.), Isoniazid (B.P.), Pyrazinamide (B.P.), Rifampicin-Isoniazid (B.P.), Rifampicin-Isoniazid-Pyrazinamide (B.P.), Ethionamide (B.P.) and Prothionamide (B.P.) - all in Tablet form. Production of bulk actives such as Ethambutol, Rifampicin and Pyrazinamide are also undertaken at Valsad, Gujrat (India).
R & D activity is a continuous on-going process and the R & D Division at Sarigam has been duly approved by the Department of Scientific and Industrial Research, (DSIR), Government of India.
The Raigad Plant, which is involved in Fermentation activity has been suitably up-graded and manufactures products like - Lovastatin, Simvastatin, DMCTC, Gentamycin, Sisomycin, etc., The Plant also exclusively manufactures a veterinary product for a foreign multinational - in fact is the only manufacturer of this product in the world.